| 000 | 01725 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517093734.0 | ||
| 264 | 0 | _c20170707 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1879-3649 | ||
| 024 | 7 |
_a10.1016/j.vph.2016.04.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhu, Dongxing | |
| 245 | 0 | 0 |
_aA novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification. _h[electronic resource] |
| 260 |
_bVascular pharmacology _c11 2016 |
||
| 300 |
_a87-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a11-beta-Hydroxysteroid Dehydrogenase Type 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCorticosterone _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEplerenone |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMifepristone _xpharmacology |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xcytology |
| 650 | 0 | 4 |
_aMyocytes, Smooth Muscle _xpathology |
| 650 | 0 | 4 |
_aPhosphates _xadministration & dosage |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Glucocorticoid _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Mineralocorticoid _xdrug effects |
| 650 | 0 | 4 |
_aSpironolactone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aVascular Calcification _xpathology |
| 700 | 1 | _aRashdan, Nabil A | |
| 700 | 1 | _aChapman, Karen E | |
| 700 | 1 | _aHadoke, Patrick Wf | |
| 700 | 1 | _aMacRae, Vicky E | |
| 773 | 0 |
_tVascular pharmacology _gvol. 86 _gp. 87-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vph.2016.04.005 _zAvailable from publisher's website |
| 999 |
_c25996046 _d25996046 |
||